Trial
NCT03090880
Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE)
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
Ministry of Health, France; National Cancer Institute, France
Condition
Venous Thromboembolism
Intervention
Tinzaparin Sodium
Why stopped
The rate of inclusion is too low to hope to reach the target of 800 patients. 59 patients were included, and their data will not meet the research objectives.
The sponsor has decided to prematurely stop inclusions on January 13, 2022.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-11-17